Strategic Collaborations Charles River Laboratories actively partners with leading biotech and academic institutions, including recent collaborations with Synthace, Gazi University, and Heriot-Watt University, presenting opportunities for joint research projects and co-developed solutions.
M&A Expansion The company has demonstrated growth through acquisitions like PathoQuest and asset purchases from private equity, indicating a readiness to expand service offerings and enter new market segments that could be targeted for upselling or cross-selling.
Innovative Capabilities Recent development of preclinical lupus assets and investments in Next Generation Sequencing quality control highlight their focus on cutting-edge technologies, offering potential sales avenues in advanced assay development and personalized medicine solutions.
Market Positioning With a robust revenue range of up to 10 billion dollars and a large workforce, Charles River is well-positioned in the biotech research industry, providing opportunities for tailored services and enterprise solutions to large pharmaceutical and biotech clients.
Technology Adoption The company's utilization of modern tech stacks like Azure, Kubernetes, and Copado indicates commitment to digital transformation, suggesting opportunities for selling complementary IT solutions, data management tools, and automation services.
$10B
$500M$1B
$1B$10B
$10B
$1B$10B
$100M$250M
$10B
$1B$10B
$10B
$1B$10B
$10BCharles River Laboratories uses 8 technology products and services including Hotjar, Azure App Service, Rive, and more. Explore Charles River Laboratories's tech stack below.
| Charles River Laboratories Email Formats | Percentage |
| First.Last@crl.com | 91% |
| Last@crl.com | 4% |
| Last.First@crl.com | 1% |
| First.Middle@crl.com | 1% |
| FLast@crl.com | 1% |
| FiLast@crl.com | 1% |
| First.L@crl.com | 1% |
| FLast@criver.com | 61% |
| First.Last@criver.com | 33% |
| FirstL@criver.com | 3% |
| LFirst@criver.com | 3% |
| FLast@agiluxlabs.com | 72% |
| First_Last@agiluxlabs.com | 10% |
| FirstL@agiluxlabs.com | 3% |
| Last.First@agiluxlabs.com | 3% |
| FiLast@agiluxlabs.com | 3% |
| First.L@agiluxlabs.com | 3% |
| First_L@agiluxlabs.com | 3% |
| First-Last@agiluxlabs.com | 3% |
Biotechnology ResearchMassachusetts, United States10001+ Employees
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Company Overview
Media & News
Funding & FinancialsCharles River Laboratories has raised a total of $1.3M of funding over 5 rounds. Their latest funding round was raised on Jun 11, 2024 in the amount of $1.3M.
Charles River Laboratories's revenue is estimated to be in the range of $1B$10B
Funding & FinancialsCharles River Laboratories has raised a total of $1.3M of funding over 5 rounds. Their latest funding round was raised on Jun 11, 2024 in the amount of $1.3M.
Charles River Laboratories's revenue is estimated to be in the range of $1B$10B
1-888-653-2347 
support@leadiq.com